More on ABT
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $114.14 |
|
|||
| Open | $114.02 | ||||
| 52 Wk High | $46.38 | ||||
| 52 Wk Low | $36.00 | ||||
| Day High | $116.61 | ||||
| Day Low | $113.45 | ||||
| P/E | 77.57 | ||||
| EPS | $1.50 | ||||
| Volume | 6,899,415 | ||||
- Abbott Labs (ABT) PT Raised to $135 at TD Cowen
- Form 8-K ABBOTT LABORATORIES For: Aug 20
- Abbott settles preterm formula NEC lawsuits for $670 million
- Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants
- Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
- Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare
- First Bellwether Trial Today Against Reckitt Benckiser’s Mead Johnson in NEC Baby Formula MDL Led by Levin Papantonio
- Form 4 ABBOTT LABORATORIES For: Aug 11 Filed by: Morrone Louis H.
- Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle
- Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
Entities mentioned with ABT
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- ARK | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
